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In a model system to study factors involved in the establishment of a persistent viral infection that may lead to
neurodegenerative diseases, Indiana and New Jersey variants of vesicular stomatitis virus (VSV) with different capacities to
infect and persist in human neural cells were studied. Indiana matrix (M) protein mutants and the wild-type New Jersey strain
persisted in the human neural cell line H4 for at least 120 days. The Indiana wild-type virus (HR) and a non-M mutant (TP6),
both unable to persist, induced apoptosis more strongly than all the other variants tested, as indicated by higher levels of
DNA fragmentation and caspase-3-like activity. Transfection of H4 cells with mRNA coding for the VSV M protein confirmed
the importance of this protein in the induction of apoptosis. Furthermore, the pan-caspase inhibitor ZVAD-fmk maintained cell
survival to about 80%, whereas inhibition of caspase-8, caspase-9, or both only partially protected the cells against death,
consistent with the fact that anti-apoptotic molecules from the Bcl-2 family also protect cells from death only partially. These
results suggest that VSV activates many pathways of cell death and that an inefficient induction of caspase-3-relatedINTRODUCTION
Neurodegenerative diseases may be linked to persis-
tent viral infections of the central nervous system (CNS).
Indeed, viral induction of long-term neuropathology is
well described for subacute sclerosing panencephalitis
and measles virus (Haase et al., 1985; Schneider-
Schaulies and ter Meulen, 1999), Theiler’s murine en-
cephalitis virus-induced demyelination disease in mice
(Miller et al., 1997; Tsunoda et al., 1997), and subtle
neurological deficit associated with lymphocytic chorio-
meningitis virus (Oldstone, 1989). The murine coronavi-
rus mouse hepatitis virus (MHV) also provides a useful
model for demyelinating diseases such as multiple scle-
rosis (Castro et al., 1994; Houtman and Fleming, 1996;
Wege et al., 1998; Buchmeier and Lane, 1999) and can
persist in neural cells (Lavi et al., 1987; Chen and Baric,
1996). Furthermore, the human counterparts of MHV,
human coronavirus strains HCoV-229E and HCoV-OC43,
present a special interest in relation to persistent viral
infection of the CNS as viral RNA was detected by RT-
PCR in human brain tissue (Arbour et al., 2000), and both
1 To whom correspondence and reprint requests should be ad-
dressed at De´partement des sciences biologiques, Universite´ du Que´-
bec a` Montre´al, P.O. Box 8888, Station Centreville, Montre´al, Que´bec,63strains can persistently infect human neural cells (Arbour
et al., 1999a, b).
A viral infection is one of several factors that, taken
together, can lead to a chronic neuropathology (Talbot et
al., 2001). In several of these pathologies, a persistent
infection, whereby a virus has elaborated a strategy of
nonlytic replication in the infected cells, often seems to
be a key factor in the triggering of illness (de la Torre and
Oldstone, 1996). Among the various viruses that have
been studied for viral and cellular functions involved in
the initiation of a persistent infection is the vesicular
stomatitis virus (VSV), a member of the Rhabdoviridae
family from the Mononegavirales order. This virus is
usually highly cytopathic, but has also been shown to
persist in cell culture (Stanners et al., 1975; Huprikar et
al., 1986; Desforges et al., 2001) and to infect the CNS
(Huneycutt et al., 1994; Plakhov et al., 1995) where at
least viral RNA can persist (Fultz et al., 1982; Barrera and
Letchworth, 1996).
The cytopathic effect (cpe) caused by VSV usually
leads rapidly to cell death. One important mechanism
that may be involved in virus-mediated cell death is
apoptosis, which appears to be induced by various
DNA and RNA viruses (see reviews by Razvi and
Welch, 1995; Teodoro and Branton, 1997; Griffin andapoptosis participates in the establishment of a persisten
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2000, 2001) and New Jersey (Koyama, 1995) strains of
VSV can induce apoptosis.
Apoptosis is a complex and highly regulated mecha-
nism that usually results in the activation of a special
type of cysteine protease called the caspases (cysteine-
dependent aspartate-specific proteases). By initiating a
complex cascade of reactions that usually involve these
caspases, the cell finally kills itself (Nunez et al., 1998;
Earnshaw et al., 1999; Hengartner, 2000). In the situation
of a viral infection, apoptosis may have various conse-
quences. The first is to limit the inflammatory response
(Teodoro and Branton, 1997; Marcellus et al., 1998), a
situation which can be beneficial to the virus for evading
the immune system of the host more efficiently. In some
cases, apoptosis may even enable virus spread, as has
been suggested for HIV (Strack et al., 1996). Neverthe-
less, apoptosis may also represent a potent defense
mechanism for the host, limiting viral proliferation in the
infected organism (Tsunoda et al., 1997; Allsopp et al.,
1998). However, cell death itself may contribute to and
enhance pathogenesis (Jelachich and Lipton, 1996; Ubol
et al., 1998). In the end, the modulation of this complex
mechanism can sometimes be profitable to the virus and
deleterious to the host. If apoptosis is not induced cor-
rectly or not induced at all in a context where it should
be, it may allow the establishment of a persistent infec-
tion by a virus that should have been eliminated other-
wise. In the present study we used an in vitro system to
investigate factors that could be associated with ineffi-
cient regulation of virus-induced apoptosis at the cellular
level and thereby with the initiation of a persistent infec-
tion in neural cells.
We report that VSV induces apoptosis in human neural
cells in culture and that this is at least in part related to
the viral matrix (M) protein. Indeed, the Indiana strain of
VSV induced apoptosis very rapidly with more than 90%
of all cells killed by 48 h postinfection (p.i.). On the other
hand, a series of M protein mutants of the Indiana strain
(Francoeur et al., 1987; Desforges et al., 2001) and the
less cytopathic wild-type New Jersey strain induced cell
death by apoptosis but to a lesser extent, thereby allow-
ing the establishment of a persistent infection of the
FIG. 1. Persistent infection of H4 cells by VSV variants. (A) Production of infectious virus was measured by plaque assay up to 120 days
postinfection. (}) T1026, ({) T1026R1, (‚) TP3, and (✘) New Jersey serotype. (B) Detection of viral proteins by indirect immunofluorescence with a
polyclonal antiviral antiserum (green-yellow) during the course of persistent infection. Magnification, 200. Cells were counterstained with Evans blue
dye (red) to allow visualization of all cells in the culture.
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neural cells. Thus, VSV may provide a good model to
characterize the importance of the regulation of apopto-
sis as a mechanism involved in the control of viral per-
sistence in cells of the central nervous system.
RESULTS
Human neural cells sustain persistent infection
The human H4 neural cell line sustained a persistent
productive infection by the M protein mutants of the
Indiana serotype and by the wild-type New Jersey for at
least 120 days (Fig. 1A, Table 1). A representative series
of microscopic immunodetections of viral proteins during
persistence in neural cells is shown in Fig. 1B. VSV
Indiana variants induced a high level of viral antigen
production in a small number of cells, whereas VSV New
Jersey induced the production of a low level of viral
antigen in the majority of cells. Figure 1A shows that the
end result in either case was similar levels of production
of infectious particles through 120 days. On the other
hand, cells infected by Indiana variants without any mu-
tation in the M gene (HR-Ind and TP6) could not sustain
long-term infection, even when low multiplicity of infec-
tion (m.o.i.) (0.01) was used to start the infection (data not
shown). In fact, all cells were killed between 48 and 72 h
p.i. when the infection was initiated at an m.o.i. of 1 by
these viruses (Fig. 2A). In comparison, cell cultures re-
mained viable throughout infection by Indiana M protein
mutants or wild-type New Jersey (Fig. 2A) even though
there was no significant difference in production of in-
fectious virus (Fig. 2B) except for mutant T1026, which
has a thermosensitive mutation in the L gene and for TP6
at 72 h p.i.
Short-term events show that infected cells die by
several pathways of apoptosis
To identify mechanisms that are important in the es-
tablishment of the persistent infection, the induction of
TABLE 1
Relation between the Studied VSV Variants’ Ability to Persist on H4
Human Neural Cells and Mutation in the M Gene Compared to
Indiana-HR
Virus M gene mutation
Other known
mutation Persistence
Indiana-HR —a No No







New Jersey 62% homologyc — Yes
a Sequence of M gene; Rose and Galione (1981).
b Sequence of M gene; Desforges et al. (2001).
c The M gene sequence of the New Jersey Hazelhurst serotype is not
known but the sequence of the Ogden serotype presents a 62% ho-
mology with Indiana; Gill and Banerjee (1986).
FIG. 2. (A) Cell survival after infection with VSV variants (m.o.i. of 1) evaluated by Trypan blue dye exclusion and (B) production of infectious virus
during short-term events (first 3 days) of infection.
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cell death in short-term infections of human neural cells
was analyzed. All viruses studied induced apoptosis of
neural cells as seen by TdT-dUTP nick end labeling
(TUNEL)-positive reaction at 16 h p.i. (Fig. 3A) and DNA
fragmentation (Fig. 3B). It is notable that the percentage
of TUNEL-positive cells was higher and the characteris-
tic DNA laddering was stronger and observed earlier in
cells infected with HR-Indiana and TP6 than in cells
infected with M mutant T1026R1 and New Jersey wild-
type viruses. Caspase activity in extracts from virus-
infected H4 cells was measured using a chromogenic
substrate for caspase-3 as an additional test for the
induction of apoptosis. This enzymatic activity was
clearly induced to a lesser extent by infection with the
Indiana M protein mutants and wild-type New Jersey
serotype viruses compared to HR and TP6 viruses (Fig.
4A). These results were confirmed by analysis of cleav-
age of procaspase-3 by Western blots (Fig. 4B). More of
the activated 17- to 19-kDa caspase-3 fragments were
generated in H4 cells infected with HR-Indiana and TP6
viruses than in cells infected with M mutant T1026R1 and
New Jersey wild-type viruses. Thus, although hallmarks
of apoptosis could be observed for all VSV variants, they
appeared weaker in Indiana M mutants and wild-type
New Jersey infections, correlating with the differences in
cell viability (Fig. 2A).
To further determine the apoptotic pathways induced
by the different VSV variants, neural cells were infected
in the presence of various apoptosis inhibitors. Infection
in the presence of a pan-caspase inhibitor of apoptosis,
ZVAD-fmk, protected H4 neural cells. Indeed, even at 2
days p.i., cells retained up to 80% of their mitochondrial
metabolic activity depending on the virus (Fig. 5A). On
the other hand, cells infected in the presence of 70 M
concentrations of inhibitors of caspase-8 (Z-IETD-fmk) or
caspase-9 (Z-LEHD-fmk) did not sustain infection as
well, as neither inhibitor was able to protect the cells
from death as efficiently as ZVAD-fmk for more virulent
nonpersisting viruses. ZFA-fmk is the negative control for
ZVAD-fmk, as it does not inhibit any known caspases. It
protected the cells to a much lesser extent (Fig. 5A).
Moreover, stable overexpression of anti-apoptotic mole-
cule Bcl-2 and to a lesser extent Bcl-XL was correlated
with an increased survival of infected cells (Figs. 5B and
FIG. 3. Comparison of virus-induced apoptosis. (A) (Left) Micrograph of TUNEL assay at 16 h postinfection (magnification, 200); (right)
quantification of TUNEL-positive cells (five fields of more than 50 cells, two independent experiments). (B) DNA fragmentation analysis on 1.8%
agarose gel stained with 0.5 g/ml ethidium bromide; m, is 100-bp DNA ladder.
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5C) and did permit the establishment of a long-term
infection for at least 2 weeks by VSV–HR-Indiana when
infection was initiated at an m.o.i. of 0.01 or less (data not
shown). On the other hand, neither of these anti-apo-
ptotic molecules led to VSV-TP6 persistence in H4 cells
(data not shown).
Inhibition of caspase-related apoptosis allows a more
effective production of virus
As ZVAD-fmk protected cells from VSV-induced
caspase-associated apoptosis, we wished to determine
whether this protection had any effect on viral replica-
tion. Measurement of infectious virus titers (plaque-form-
ing units, PFU) indicated that inhibition of caspases al-
lowed production of infectious virus for a longer period of
time (Fig. 6A). As shown in Fig. 6B, inhibition of caspases
using ZVAD-fmk led to an increased production of infec-
tious virus by up to2 logs for all Indiana variants. Thus,
inhibition of apoptosis appears to participate in a better
propagation of infectious VSV between 45 and 72 h p.i.,
with the exception of wild-type New Jersey (Fig. 6B).
M protein participates in DNA fragmentation
Recent results (Despars et al., unpublished results;
Kopecky et al., 2001) point to the involvement of the M
protein in the apoptosis induction process. Thus, we
tested whether production of M protein in the absence of
other viral components was sufficient to induce apopto-
sis in H4 cells. In view of the inhibitory effect of M protein
on host transcription, M protein was expressed from
transfected mRNA rather than plasmid DNA, since M
protein inhibits its own expression from DNA vectors that
depend on host transcriptional activity (Black and Lyles,
1992; Black et al., 1994). Expression of either wild-type or
T1026R1 mutant M protein alone in H4 neural cells in-
duced DNA fragmentation at 18 h posttransfection as
shown in Fig. 7, which is representative of two different
experiments. In both experiments, it appeared that wild-
type M protein led to a stronger positive TUNEL reaction
than the T1026R1 mutant and vehicle (lipofectamine
alone), in agreement with DNA fragmentation observed
during whole virus infection (Figs. 3A and 3B).
DISCUSSION
Given the observation that several viruses induce or
modulate apoptosis, it appears that this process is a key
factor in the complex regulation that takes place to con-
trol the infection, including modulation from an acute
infection to viral persistence. The central nervous system
represents a privileged site for viral persistence and this
could indicate relevance to the development of neuro-
logical disorders. Therefore, we wished to study how a
viral infection can become persistent in a neural cell
model. For that purpose, we used VSV, a usually highly
cytopathic virus that has been shown to induce apopto-
sis (Bi et al., 1995; Balachandran et al., 2000, 2001;
Koyama, 1995) as well as to persist in the nervous sys-
tem (Fultz et al., 1982; Barrera and Letchworth, 1996) and
for which we possess a series of attenuated mutants.
Induction of DNA fragmentation and activation of
caspase-3-like proteases are usually important hall-
marks of apoptosis, and their extent is correlated with
the degree of apoptosis. The fact that a reduced activa-
tion of these markers occurs in cells infected by Indiana
M protein mutants and wild-type New Jersey compared
to Indiana wild type (Figs. 3 and 4) is crucial as it
correlated with a limited induction of cell death, thereby
allowing survival of a large portion of the infected cells
(Fig. 2A) and providing the virus a reservoir to maintain
itself (Fig. 1). Expression of the M protein alone in H4
cells induced apoptosis, as seen by DNA fragmentation
(Fig. 7). The apparent difference in the degree of apopto-
sis induced by wild type and the T1026R1 mutant M
protein is very interesting as it correlates with results
observed during viral infection (Figs. 3A and 3B) and with
the fact that the only difference between the wild-type
virus HR-Ind and the mutant T1026R1 genomes is in the
FIG. 4. Evaluation of caspase-3 during infection. (A) Measurement of
enzymatic activity was performed at 3, 17, 24, and 42 h postinfection for
Indiana M mutants and New Jersey serotype and at 3, 17, and 24 h
postinfection for HR-Ind and TP6, the two variants that do not persist.
Comparison was performed at 17 and 24 h and statistical analysis
(ANOVA) shows that the difference in caspase-3 activity induction is
significant between the viruses that did persist and those that did not,
as indicated by the P values. **P  0.01, differences are significant;
**P  0.001, differences are highly significant. Values of fold induction
represent the mean for five different experiments performed in dupli-
cate. The bars represent the standard deviations. (B) Evaluation of
caspase-3 activation by Western blot analysis. Cleavage of pro-
caspase-3 (32 kDa) into smaller fragments (19 and 17 kDa) indicates
that caspase-3 is activated at different levels by the different VSV
variants at 18 h postinfection. Lane 1, mock 18 h; lane 2, mock 40 h; lane
3, HR 18 h; lane 4, TP6 18 h; lane 5, T1026R1 18 h; lane 6, TP3 18 h; lane
7, New Jersey 18 h.
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M gene, as we have previously shown (Desforges et al.,
2001; see Table 1). Furthermore, this difference in induc-
tion of apoptosis between wild-type and mutant M pro-
tein is supported by recent results which indicate that
expression of a similar mutant M protein expressed
alone in HeLa or BHK cells activates little if any
caspase-3 (Kopecky et al., 2001).
Overexpression of Bcl-2 has already been shown to be
associated with persistent infection of cells by other
cytopathic viruses such as Sindbis virus (Levine et al.,
1993), Semliki Forest virus (Scallan et al., 1997), and
Japanese encephalitis virus (Liao et al., 1998). In our
system, cells overexpressing Bcl-XL and especially Bcl-2
survived significantly better to infection (Figs. 5B and 5C)
especially when infection was done at a low m.o.i. This
ectopic expression of anti-apoptotic molecules even al-
lowed HR-Indiana virus to persist in culture when the
infection was initiated at 0.01 PFU/cell (data not shown),
indicating that those anti-apoptotic Bcl-2 family members
are of some importance for the control of VSV-induced
apoptosis and possible viral persistence. Further analy-
ses of the possible modulation of regulatory proteins
FIG. 5. Modulation of apoptosis allows longer cell survival. (A) Evaluation of metabolic activity of the cells by MTS/PMS at 48 h postinfection (m.o.i.
1) reveals caspase-dependent apoptosis (units are percentage of metabolic activity measured by optical density at 540 nm as compared to
mock-infected cells). DMSO is the inhibitors’ solvent, ZFA is a negative control for caspase inhibitors, ZVAD-fmk is a pan-caspase inhibitor, Z-IETD-fmk
is a caspase-8 inhibitor, and Z-LEHD-fmk is a caspase-9 inhibitor. (B) Evaluation of viability by Trypan blue dye exclusion of H4 cell subpopulation
overexpressing Bcl-2. Bcl-2 overexpression delays cell death significantly. (C) Evaluation of metabolic activity of the H4 cells. Five clones
overexpressing Bcl-2 or Bcl-XL were infected and metabolic activity was measured by MTS/PMS at 48 h postinfection (m.o.i. of 1).
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such as anti-apoptotic Bcl-2 and Bcl-XL and of pro-
apoptotic Bax and Bid are currently being performed to
further characterize the mechanisms underlying VSV-
induced apoptosis.
Our results so far indicate that there may be other
pathways involved in VSV-induced apoptosis besides the
mitochondrial pathway which is regulated by the Bcl-2
family of proteins. Indeed, inhibition of caspase-9 pro-
tected cells from death only partially and for both Indiana
variants with wild-type M protein (HR and TP6), to the
same level as inhibition of caspase-8 (Fig. 5A), which can
be independent of mitochondria-related apoptosis by
directly activating the effector caspase-3 (Hentgartner,
2000). Partial protection by caspase-8 and -9 inhibitors
therefore suggests that intrinsic (caspase-9 associated)
and extrinsic (caspase-8 associated) pathways of apo-
ptosis are both important in regulating VSV-induced ap-
optosis, as is the case for Sindbis virus (Nava et al.,
1998). Moreover, the pan-caspase inhibitor ZVAD-fmk
provided protection from VSV-induced cell death, as up
to 80% of mitochondrial metabolic activity remained at
48 h p.i. (Fig. 5A) and up to 70% at 68 h p.i. (data not
shown). This indicates that caspase-related apoptosis is
implicated in cell death but also that a fraction of the
cells may die by alternative pathways such as passive
necrosis. Poliovirus has been shown to induce cell death
by distinct pathways which could lead to caspase-re-
lated apoptosis or classical cpe leading to death even in
the presence of caspase inhibitors (Agol et al., 1998).
Moreover, ZVAD-fmk did not completely provide protec-
tion from cell rounding, a well-documented VSV-induced
cpe. Others have recently observed the same pattern of
survival during VSV infection of C6 rat glial cells when
using ZVAD-fmk and specific inhibitors of caspase-8, -9,
or even -3 (Balachandran et al., 2001). Even though the
mean metabolic activity of H4 cells infected by M mutant
T1026R1 appeared to be reduced in the presence of
caspase-9 inhibitor (Z-LEHD) compared to ZVAD, the
difference is not significantly different (ANOVA, P 0.05).
This could indicate differences in the induction of apo-
FIG. 6. Infectious virus production in the presence or in the absence of caspase-related apoptosis inhibitors. (A) Inhibition of caspases by
pan-caspase inhibitor ZVAD-fmk led to increased production of viruses between 45 and 72 h p.i. (B) Ratio of infectious virus production (PFU) in the
presence of caspase inhibitor ZVAD-fmk over infectious virus production in the presence of DMSO at 45 and 72 h indicated a better production of
infectious virions for all Indiana variants when caspases were inhibited.
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ptotic pathways between M mutants and wild-type Indi-
ana. On the other hand, like cells infected with wild-type
Indiana virus, infection with this mutant in the presence
of both Z-LEHD and Z-IETD did not protect the cells from
death as well as ZVAD (ANOVA, P  0.01), suggesting
that other proteases are involved in the induction of
apoptosis. Calpain is a cysteine protease that has been
linked to activation of caspase-3 in rat brain (Blomgren et
al., 2001), and it can be activated during reovirus infec-
tion (Debiasi et al., 1999). Given these facts, character-
ization of calpain activation during infection by our dif-
ferent VSV variants is currently under way to determine
whether it could account for differences in caspase-3
activation by the less cytopathic viruses.
It has been reported that VSV was partially inhibited in
its capacity to produce infectious virions in Hep-2 cells
undergoing apoptosis (Koyama et al., 1998). Despite a
10-fold reduction in virion production at 10 h p.i. when
cells were undergoing apoptosis, these authors sug-
gested that the replicative cycle of VSV was not signifi-
cantly affected. Although our results indicate the same
tendency, the differences appeared at later times, ZVAD-
fmk being associated with a better production of infec-
tious virions for Indiana variants between 45 and 72 h p.i.
(Figs. 6A and 6B). At this time in the infection, the in-
crease in titer of infectious virions reached its maximum
and went as high as 283-fold for TP6 when caspases are
inhibited by ZVAD-fmk. This is in agreement with the fact
that during a normal infection, there is an important drop
of plaque-forming unit production for TP6 between 45
and 72 h (Fig. 2B).
In conclusion, it appears from our results that apopto-
tic cell death is important during VSV infection and that a
restricted activation of this pathway by less cytopathic
variants of VSV may lead to a persistent infection of
neural cells. Moreover, VSV-induced apoptosis during
wild-type Indiana infection seems to be a potent mech-
anism to limit viral replication and to prevent viral per-
sistence in a human neural cell line. Infection of neural
cells in vitro does not necessarily re-create all the com-
plexity of the CNS but viral persistence at this privileged
site has been extensively described. Of course, further
investigation must be made to correlate our results to the
situation in vivo. However, it is already known that VSV
mutant T1026 is associated with possible persistence
and delayed CNS pathology in newborn hamsters (Stan-
ners et al., 1975). Moreover, modulation of apoptosis has
been described as a viral strategy that can permit the
establishment of persistence in other systems (Shen and
Shenk, 1995; Hardwick, 1998; Kalvakolanu, 1999). Hall-
marks of apoptosis have been reported to appear in the
mouse olfactory bulb during VSV Indiana wild-type infec-
tion. Thus, studying how the apoptotic process may be
modulated or impaired during infection of neural cells
should further our understanding of the establishment of
a long-term infection that may be associated with neu-
rodegenerative diseases. Further investigation also re-
mains necessary to explain the complete pathways of
programmed cell death related to VSV infection of neural
cells. In trying to identify what cellular and viral factors
are important for cell death to happen it should be
possible to understand why and how persistent infection
can be established and maintained in neural cells by
usually cytopathic viruses such as VSV. Furthermore,
knowing that VSV is currently studied in relation to its
possible use in cancer therapy (Stojdl et al., 2000; Bal-
achandran et al., 2001), it is of major importance to
understand how VSV persistence may appear in infected
cells, especially in the CNS.
MATERIALS AND METHODS
Cell lines and viruses
The simian kidney fibroblast Vero cells (ATCC-CCL-81)
used for virus titration experiments were grown to 100%
confluence before infection at 37°C in a 5% (v/v) CO2
atmosphere, in MEM  medium supplemented with 10%
FIG. 7. VSV M protein is related to the induction of apoptosis. H4 cells
were seeded the day before transfection in 4-well slides and left
untreated (a,e), treated with lipofectamine alone (b,f), transfected with
T1026R1 mutant M mRNA (c,g), or transfected with wild-type M mRNA
(d,h). Cells were fixed 18 h posttransfection and the TUNEL reaction
was performed. The same micrographs are shown under fluorescence
for TUNEL assay (a,b,c,d) and phase contrast (e,f,g,h). Magnification,
200 (representative field of two independent experiments).
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(v/v) calf serum, penicillin G (100 units/ml), streptomycin
sulfate (100 g/ml), and fungizone (2.5 g/ml amphoter-
icin B and 2.5 g/ml sodium deoxycholate). The human
neural cell line H4 (ATCC-HTB-148) was grown the same
way except that DMEM supplemented with 10% (v/v) fetal
calf serum (FCS) was used. The wild-type HR strain of
VSV Indiana has been described elsewhere, as were the
M mutants derived from it (Francoeur et al., 1987; Des-
forges et al., 2001). The New Jersey Hazelhurst strain
was a gift from Dr. Yong Kang (University of Western
Ontario). Experimental infections were performed at
m.o.i. values ranging from 0.01 to 1. For the infection of
the H4 cells, all viruses were diluted in PBS containing
2% (v/v) FCS and incubated with the cells in a minimal
volume for 1 h at 37°C to allow adsorption and penetra-
tion into the cells, before being washed once with PBS
and addition of complete DMEM (all cell culture products
were from Canadian Life Technologies).
Indirect immunofluorescence
H4 cells (1.5  104) persistently infected were seeded
on 12-well multitest slides (ICN Biomedicals) and fixed
the next day with cold acetone. Detection of viral antigen
was performed the next day using a rabbit polyclonal
antibody against VSV antigen (1/500) as primary anti-
body, and secondary antibody was F(ab)2 anti-rabbit
coupled to FITC (1/100). After detection of viral antigen
with specific antibody, cells were counterstained with
Evans blue dye to allow the visualization of all the cells
in the culture.
Cell viability
Viability of the cells was estimated by Trypan blue dye
exclusion. Briefly, after a 2-min treatment with 0.25%
trypsin (w/v), cells were resuspended in 2 ml of complete
DMEM. An aliquot was then mixed with 1 vol of 0.4%
(w/v) Trypan blue and the viability of the cells was esti-
mated by microscopic observation on an hemacytome-
ter.
Metabolic activity of the cells in the presence of
apoptosis inhibitors
The MTS/PMS tetrazolium assay (Cory et al., 1991)
was used to measure the survival of the culture after
infection. MTS (Promega) was added to the culture me-
dium (final concentration of 0.6 mM) with PMS (Sigma–
Aldrich) (final concentration of 0.014 mM). The reduction
of MTS, a measure of mitochondrial respiration and
therefore a direct indication of cell viability and viral
cytotoxicity, is monitored by optical density reading at
540 nm. The cells were preincubated for 2 h with com-
plete DMEM high glucose alone or with medium con-
taining 0.2% (v/v) DMSO, 100 M ZFA-fmk, or 100 M
ZVAD-fmk (Enzyme System Products). The infection was
performed as described earlier at an m.o.i. of 1 for 1 h
and then complete DMEM was added, either alone or
with 0.2% (v/v) DMSO, 100 M ZFA-fmk (inhibitor of cys-
teine proteases other than caspases), or 100 M ZVAD-
fmk (pan-caspase inhibitor), 70 M Z-IETD-fmk (inhibitor
of caspase-8), or 70 M Z-LEHD-fmk (inhibitor of
caspase-9) (Enzyme System Products).
Establishment of cell lines and clones overexpressing
Bcl-2 and Bcl-XL
Transfection of 1 g of DNA from pRSV-HA-Bcl-2-neo
or pcDNA-HA-Bcl-XL-neo (a kind gift from Dr. Gordon
Shore, McGill University) or pRSV-neo as control (a gift
from Dr. E´ric Rassart, University of Quebec at Montreal)
was performed using 10 l of lipofectamine (Invitrogen–
Life Technologies) on 2  105 H4 cells at 2/3 confluence
in 6-well plates (Falcon Catalog No. 3046). Selection of
H4 cell subpopulations and isolated clones overexpress-
ing either Bcl-2 or Bcl-XL was performed with G418
(Invitrogen–Life Technologies) at 1 mg/ml and then kept
under selection at 500 g/ml of this selecting agent. The
viability of subpopulations composed of 50 different
clones overexpressing Bcl-2 was evaluated by Trypan
blue dye exclusion, and the metabolic activity of isolated
clones overexpressing either Bcl-2 or Bcl-XL was evalu-
ated by the MTS/PMS tetrazolium assay.
Infectious viral particle production
Aliquots of medium were taken at different times dur-
ing the course of the infection and titrated to evaluate
whether or not the infection was productive. The plaque
assay was performed by infecting confluent Vero cells
grown in 6-well plates (Falcon Catalog No. 3046) using
serial dilutions in PBS supplemented with 2% (v/v) FCS.
After a 1-h incubation in a minimal volume, complete
MEM  medium containing 0.2% (w/v) agarose was
added (Desforges et al., 2001). Infectious virus titers
were expressed as plaque-forming units per milliliter.
DNA fragmentation and TUNEL
After infection, DNA was extracted from 4  106 cells
as described elsewhere (Appel et al., 2000). Briefly, de-
tached and adherent cells were collected, washed with
cold PBS, and lysed on ice for 1 h in 1 ml of cold lysis
buffer (10 mM Tris, pH 7.5, 10 mM EDTA, and 0.2% (v/v)
Triton X-100). Lysates were centrifuged at 10,000 g for 20
min at 4°C, and low-molecular-weight DNA was ex-
tracted by conventional phenol, phenol–chloroform, and
chloroform extractions and precipitated with ethanol. The
pellet was resuspended in 25 l of water and treated for
30 min with RNase A (10 g/l) at 37°C. Samples were
then run on a 1.8% (w/v) agarose gel in Tris–borate–EDTA
buffer stained with ethidium bromide (0.5 g/ml).
For TUNEL staining, 1.5  104 cells were infected on
16-well glass slides (Nunc), fixed with freshly prepared
4% (v/v) paraformaldehyde in PBS at room temperature,
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and permeabilized with 0.2% (v/v) Triton X-100–0.2% (w/v)
sodium citrate for 3 min on ice. Labeling was performed
according to the manufacturer’s instructions (Roche Di-
agnostics) except that the labeling solution was previ-
ously diluted by 50% with a solution containing 30 mM
Tris, pH 7.2, 140 mM sodium cacodylate, and 1 mM
CoCl2.
Measurement of caspase-3-like activity
Induction of caspase-3-like activity in cells was mea-
sured with a caspase-3 colorimetric assay (R&D Sys-
tems) as described by the manufacturer. Briefly, 4  106
cells were infected at an m.o.i. of 1, and floating and
adherent cells were recovered together at the indicated
times postinfection. After two washes in cold PBS, cells
were counted, lysed in buffer (25 l per 1  106 cells),
and left on ice for 10 min. Lysates were cleared by a
1-min centrifugation at 10,000 g and kept at 80°C until
analysis. Caspase-3-like activity was measured by opti-
cal density reading at 405 nm after a 2-h incubation
period at 37°C.
Fifty micrograms of total cell extract proteins was
migrated on a 12.5% acrylamide gel and transferred to a
PVDF membrane (Millipore) using a semidry apparatus
(Bio-Rad). Western blotting was performed using anti-
caspase-3 rabbit antiserum (a kind gift from Dr. Michele
Barry, University of Alberta), diluted 1/5000 in TBS–0.1%
Tween-20 containing 5% nonfat dry milk. Secondary an-
tibody was anti-rabbit HRP (Amersham Biosciences) di-
luted 1/5000 in TBS–0.1% Tween-20. Visualization was
performed using an ECL detection kit (Amersham Bio-
sciences).
Cloning and transfection of viral M gene in neural
cells
The M gene cDNAs (wild-type MTP6 and N-terminal
mutant MT1026R1) were prepared as described else-
where (Desforges et al., 2001) and cloned in pSD4, a
plasmid derived from vector pSP65 (Invitrogen–Life Tech-
nologies), which contains the Sp6 phage promoter for in
vitro transcription. The mRNAs were synthesized in vitro
using mMessage mMachine Sp6 kit (Ambion). The quan-
tity and quality of mRNAs were double-checked by opti-
cal density reading at 260 nm and by electrophoresis on
agarose gel.
The day before transfection, H4 cells were seeded at
3  104 cells/well in 4-well slides (Nunc). Cells were
transfected with 0.15 g of mRNA transcribed in vitro and
2.5 l of lipofectamine according to the manufacturer’s
instructions (Invitrogen–Life Technologies). Cells were
then fixed with 4% (w/v) paraformaldehyde 18 h post-
transfection. The TUNEL reaction was performed as in-
dicated for VSV infections.
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